MRNA, SPCX, MSTR and More: 5 Stocks Investors Couldn't Stop Buzzing About This Week
Key takeaways
- Retail hype turned corporate news into sharp price swings across biotech, retail, AI, and space stocks this week.
- MRNA shares surged >177% on Aug. 19
- WMT revenue $187.9 billion, up 5.9%
- WMT adjusted EPS $0.81
What happened
Retail investors focused on five stocks—Moderna (MRNA), Walmart (WMT), Strategy (MSTR), Broadcom, and SpaceX —during the week of Aug. 17‑21, driven by earnings beats, AI and space sector momentum, and corporate news. MRNA announced a Phase 3 success for its melanoma vaccine, sending the stock up more than 177% before a pullback. WMT beat Q2 estimates but saw shares fall 9% after guidance cuts and tariff‑refund plans. MSTR sold 3.46 million shares for $334 million, used proceeds for dividends…
Why it matters
The week’s moves illustrate how retail sentiment can amplify corporate news and sector trends. MRNA’s vaccine breakthrough could reshape oncology and boost long‑term valuation, while WMT’s mixed guidance highlights consumer softness amid high fuel costs. MSTR’s share sale and Bitcoin exposure show how crypto holdings…
Short-term and longer-term
Short-term. Short‑term traders should watch MRNA for a potential rebound after the 177% spike, WMT for any further guidance revisions, MSTR for Bitcoin price swings, AVGO for AI‑related earnings beats, and SPCX for dilution events.
Longer-term. Over the next few months, investors may consider MRNA’s vaccine pipeline as a long‑term growth driver, WMT’s adjusted guidance as a signal of retail resilience, MSTR’s Bitcoin exposure as a hedge against inflation,…